Five things to look for in Twitter’s results
July 25, 2019
California, four automakers defy Trump, agree to tighten emissions rules
July 25, 2019

Eliquis, Orencia sales propel Bristol-Myers to strong second quarter

Bristol-Myers Squibb Co , which is set to buy biotechnology company Celgene Corp for $74 billion, posted better-than-expected second-quarter profit on Thursday on strong sales of blood thinner Eliquis and rheumatoid arthritis treatment Orencia.

Powered by WPeMatico